News
-
Monday 11th June 2018
Research at Leeds finds heart attacks more deadly during colder months
Cardiologists at Leeds have found that heart attacks are more deadly during colder months than in warmer months. The West Yorkshire Primary Percutaneous Coronary Outcome study looked at information from over 4000 patients. The overall number of heart attacks was consistent throughout the year; however the risk of dying within 30 days of a severe heart attack was almost 50%...
Read more
-
Thursday 26th April 2018
Joint Leeds Clinical Research Facility- Leeds Biomedical Research Centre PPI Strategy Released
We are pleased to announce that our joint Patient and Public Involvement (PPI) Strategy has been released. This strategy is the result of hard work by members of staff, Patient...
Read more
-
Friday 6th April 2018
Leeds Teaching Hospitals NHS Trust is delighted to join a network of national Bioresource centres
Leeds Teaching Hospitals Trust (LTHT) has been successful in securing National Institute for Health Research (NIHR) BioResource Centre designation and funding from January 2018 to March 2022. The NIHR BioResource...
Read more
-
Friday 6th April 2018
LCRF Hosts Visit by the Department of Health
The LCRF was happy to host a visit by a team from the Department of Health office in Leeds. Pictured below from left to right are: Emma Lowe, Research Policy Senior...
Read more
-
Wednesday 4th April 2018
Sending Off a Long Time Member of Staff
Chief Executive of the Leeds Teaching Hospitals Trust Julian Hartley joined the team at the Clincial Research Facility in Bexley Wing on Tuesday to wish Lynda Garbutt, Research Support Worker,...
Read more
-
Tuesday 16th January 2018
Leeds 3rd Highest Recruiter in world for MelMart Study
The Leeds Teaching Hospitals Trust (LTHT), with the support of the Leeds Clinical Research Facility (LCRF), is the third highest recruiter world-wide for the MelMart study. This study (Melanoma Margins...
Read more
-
Tuesday 28th November 2017
New trial will assess viral treatment for brain tumours
Recruitment has just begun for an early phase trial into an immunotherapy treatment for a form of brain cancer known as glioblastoma multiforme. Glioblastoma is the most common high-grade primary brain...
Read more